financetom
Business
financetom
/
Business
/
Market Chatter: Airbus CEO Says 'Not Unlikely' It Could Acquire Portions of Spirit Aerosystems from Boeing Following Merger
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Airbus CEO Says 'Not Unlikely' It Could Acquire Portions of Spirit Aerosystems from Boeing Following Merger
Apr 11, 2024 9:01 AM

11:40 AM EDT, 04/11/2024 (MT Newswires) -- Spirit Aerosystems' ( SPR ) assembly facilities in North Carolina and Northern Ireland eventually could become part of Airbus if Boeing ( BA ) is able to complete its proposed acquisition of the airplane components manufacturer, Airbus Chief Executive Guillaume Faury said in a Reuters interview on Thursday.

Boeing ( BA ) and Spirit said on March 1 they were pursuing a potential merger, nearly two decades after Boeing ( BA ) spun off its components and assembly subsidiary. Roughly 80% of Spirit's yearly business remains connected to Boeing ( BA ) but the company also produces fuselages and other parts for additional aircraft companies, including Airbus.

Faury told Reuters on Thursday it was "not unlikely" that Airbus could acquire Spirit facilities currently producing aircraft parts for the company, adding Airbus would have a "word to say" about where the two factories ended up. Airbus also has a change-of-control clause connected with the facility in Belfast, Northern Ireland, where Spirit builds wings for Airbus and Faury said antitrust regulators in the US and European Union similarly will have a say in how a possible merger is structured.

Airbus recently confirmed to MT Newswires it was engaged in "early-stage discussions on a variety of options, including acquiring from Spirit Aerosystems ( SPR ) some of the activities that they carry out for us."

Airbus, Boeing ( BA ) and Spirit did not immediately respond to requests seeking additional comment from MT Newswires on Thursday.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 33.72, Change: -0.47, Percent Change: -1.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airbus CEO upbeat on new engine technology, but jury still out
Airbus CEO upbeat on new engine technology, but jury still out
Sep 10, 2024
WASHINGTON (Reuters) - The head of European planemaker Airbus said novel open-rotor technology being tested by engine maker CFM International offers promising efficiencies and reductions in emissions but that the jury is out on whether it will be viable. Chief Executive Guillaume Faury also told reporters on the sidelines of the Global Aerospace Summit, hosted by the U.S. Chamber of...
Brookfield Plans To Invest Up To $1.1B in eFuels: Details
Brookfield Plans To Invest Up To $1.1B in eFuels: Details
Sep 10, 2024
Brookfield Asset Management Inc shares are trading lower on Tuesday. The company disclosed a strategic funding partnership with Infinium to invest up to $1.1 billion to advance eFuels production. As per the deal, Brookfield will invest more than $200 million in Infinium and its Project Roadrunner in West Texas, with up to an additional $850 million for other global Infinium eFuels...
FTC tells Seven & i it intends to probe potential Couche-Tard deal, source says
FTC tells Seven & i it intends to probe potential Couche-Tard deal, source says
Sep 10, 2024
NEW YORK (Reuters) - The U.S. Federal Trade Commission has notified Seven & i of its intention to investigate a potential takeover of the convenience store chain by Canada's Alimentation Couche-Tard over antitrust concerns, a source familiar with the matter said. Couche-Tard proposed to buy Seven & i for $38.5 billion, an offer that the Japense retail giant rejected, in...
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
Sep 11, 2024
Sept 10 (Reuters) - UnitedHealth Group ( UNH ) said on Tuesday it will remove AbbVie's ( ABBV ) blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and recommend less expensive biosimilar versions of the medicine instead. UnitedHealth ( UNH ) said Amgen's ( AMGN ) Amjevita will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved